Publication
  • EHA •
  • 13 June, 2026 •
  • •

Real-world hemoglobin profiles and transfusion burden in patients with paroxysmal nocturnal hemoglobinuria receiving complement inhibitors: A US claims analysis

Carlos de Castro, Peter Blandino, Fiston Vuvu, Enrico Zanardo, Lynn Huynh, Robert Schell, Nathaniel Downes, Yixin Yang, Mei Sheng Duh, Peter Hillmen

Publication
  • EHA •
  • 11 June, 2026 •
  • •

Sustained long-term real-world effectiveness and safety of pegcetacoplan in patients with PNH: ongoing COMPLETE Phase 4 study

Lenka Mastíková, Carmen Gonzalez Gonzalez, Anna-Elina Lehtinen, Roochi Trikha, Håkan Malmström, Luis López Lázaro, Michael O' Malley, Benjamin Chin Yee, Danny Hsu, Régis Peffault de Latour

Publication
  • ERA •
  • 4 June, 2026 •
  • •

Decreasing rates of injection site reactions over time: Long-term outcomes across multiple indications support pegcetacoplan for C3G/primary IC-MPGN

Nabil Melhem, Antonio Mastrangelo, Daniel Zecher, Abdallah S Geara, Carla M Nester, Sheena Patel, Liza Alkhori Franzén, Andrew Carrel, Carlos de Castro, Daniel P Gale, Richard J. Kelly

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Real-World Clinical Characteristics and Treatment Outcomes in PNH Patients Prescribed Pegcetacoplan: Insights of Complement Inhibitor-Experienced and -Naïve Patients Across Europe, the United States and Canada  

Jens Panse , Koo Wilson, Brianne Kerr, Sam Williamson, Susanna Libby, Yasmin Taylor, Peter Hillmen, David Dingli

Sign up for alerts